Kforce Clinical Research Flex LLC Tampa, FL - 33605

Kforce Clinical Research Flex LLC is categorized under Medical Research in Tampa, FL and active since 2012.

Kforce Clinical Research Flex LLC was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.

If you are seeking more information, feel free to contact Joe Liberatore at the company’s single location by writing to 1001 East Palm Avenue, Tampa, Florida FL 33605 or by phoning (813) 552-5000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Kforce Clinical Research Flex LLC
Contact Person: Joe Liberatore
Address: 1001 East Palm Avenue, Tampa, Florida 33605
Phone Number: (813) 552-5000
Website Address: kforce.com
Annual Revenue (USD): $50.000 to $99.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 541720
Share This Business:

Kforce Clinical Research Flex LLC was started in 2012 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Joe Liberatore for inquiries that concern Kforce Clinical Research Flex LLC by calling the company number (813) 552-5000, as your correspondence is most welcome. Additionally, the physical location of the single location of Kforce Clinical Research Flex LLC can be found at the coordinates 27.962184,-82.449758 as well as the street address 1001 East Palm Avenue in Tampa, Florida 33605.

For its online presence, you may visit Kforce Clinical Research Flex LLC’s website at kforce.com and engage with its social media outlets through on Twitter and on Facebook.